DIHYDROERGOTAMINE MESYLATE - Food and Drug Administration

Set ID
803e1b3a-35b6-0bc8-229b-d2f7e8a7ffd4
Type
Indexing - Product Concept
Effective date
2025-05-16
Version
5
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA ® (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946Product nameImpel Pharmaceuticals LLC2026-09-03
These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946Product nameSatsuma Pharmaceuticals, Inc.2026-06-22
Dihydroergotamine Mesylate Injection, USP Rx onlyProduct nameMilla Pharmaceuticals Inc.2026-05-26
DIHYDROERGOTAMINE MESYLATE Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx OnlyProduct nameSomerset Therapeutics, LLC | Mipharm S.p.A2026-03-24
Dihydroergotamine mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected.Product nameAdvagen Pharma Ltd | Mipharm, S.p.A.2026-01-07
Dihydroertotamine Mesylate Nasal Spray, 4 mg/mLProduct nameCipla USA Inc. | Mipharm SpA2025-12-29
Dihydroergotamine Mesylate Nasal Spray The solution used in Dihydroergotamine Mesylate Nasal Spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx OnlyProduct nameHikma Pharmaceuticals USA Inc. | MIPHARM SPA2025-12-12
These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946Product nameAmneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited2025-10-04
Dihydroergotamine Mesylate Nasal SprayProduct nameTrifluent Pharma, LLC2025-09-30
These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946Product nameAmneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited2025-05-15
These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946Product nameSatsuma Pharmaceuticals, Inc.2025-05-08
Dihydroergotamine Mesylate Nasal SprayProduct nameOceanside Pharmaceuticals | MIPHARM SPA2025-03-06
Dihydroergotamine Mesylate Injection, USPProduct nameProvepharm Inc.2025-02-25
These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA™ (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946Product nameImpel Pharmaceuticals LLC2025-01-17
DIHYDROERGOTAMINE MESYLATE INJECTION, USP Rx onlyProduct nameHikma Pharmaceuticals USA Inc.2024-03-15
Dihydroergotamine Mesylate Injection, USPProduct nameGland Pharma Limited2023-08-22
Dihydroergotamine Mesylate Injection, USPProduct nameBaxter Healthcare Corporation | Siegfried Hameln GmbH2023-07-14
DIHYDROERGOTAMINE MESYLATE INJECTION, USP Rx onlyProduct nameHikma Pharmaceuticals USA Inc.2023-03-17
Dromelate Injection SystemProduct nameIT3 Medical LLC2022-02-23
Dihydroertotamine Mesylate Nasal Spray, 4 mg/mLProduct nameExelan Pharmaceuticals, Inc. | Mipharm S.p.A., Italy2020-12-10